![](/img/cover-not-exists.png)
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin
Gee, Jason, Bailey, Howard, Kim, KyungMann, Kolesar, Jill, Havighurst, Tom, Tutsch, Kendra D., See, William, Cohen, Michael B., Street, Nick, LeVan, Leon, Jarrard, David, Wilding, GeorgeVolume:
73
Language:
english
Journal:
The Prostate
DOI:
10.1002/pros.22644
Date:
June, 2013
File:
PDF, 287 KB
english, 2013